KPM-2

N/A

Report date: 2025/01/26 18:38:08

NME

Base Information

Drug NameKPM-2

Drug Alias Namesirtuin 2 inhibitor (Ono Pharmaceutical/Kyoto Prefectural University of Medicine/Tokyo Metropolitan Institute of Gerontology/University of Eastern Finland)KPM-2

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors

TargetsNAD-dependent protein deacetylase sirtuin-2

Therapy Area/IndicationsNerve DegenerationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFinlandJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOno Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesKyoto Prefectural University Tokyo Metropolitan Institute Of Gerontology University Of Eastern Finland +[4]

Inactive CompaniesN/A

Active IndicationsNerve DegenerationNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A